BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
BRCA1
,
glucose metabolic process
,
Hepatitis
,
Prostate
,
Holistic medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bromperidol
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
ATF3
APP
NUDT21
DDIT4
INHBE
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
KRIGE_AMINO_ACID_DEPRIVATION
NAGASHIMA_NRG1_SIGNALING_UP
ELVIDGE_HYPOXIA_UP
regulation of lipid metabolic process
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromp…
Bromperidol decanoate (depot) for schizophrenia.
Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromper…
Severe hypotension and ventricular fibrillation during combined general and epidural anesthesia in a…
Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophre…
Pharmacovigilance in Gerontopsychiatric Patients
Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction
A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial…
PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ